Study results show conjugate therapy produced remissions in one-third of patients with drug-resistant ovarian cancer

by Dana-Farber Cancer InstituteAntitumor activity of mirvetuximab soravtansine. (A) Maximum percentage change in target lesion size from baseline. Best response according to RECIST is indicated b

Updated on: January 30,2024 18

Study results show conjugate therapy produced remissions in one-third of patients with drug-resistant ovarian cancer

by Dana-Farber Cancer InstituteAntitumor activity of mirvetuximab soravtansine. (A) Maximum percentage change in target lesion size from baseline. Best response according to RECIST is indicated b

Updated on:January 30,2024 18

Researcher looks for ways to detect deadly ovarian cancer before it develops

by Denise Heady,University of California, Los AngelesDr. Beth Karlan. Credit: Milo Mitchell/UCLAOut of the 22,240 women in the United States who are diagnosed with ovarian cancer every year, onl

Updated on: June 04,2024 4

Researcher looks for ways to detect deadly ovarian cancer before it develops

by Denise Heady,University of California, Los AngelesDr. Beth Karlan. Credit: Milo Mitchell/UCLAOut of the 22,240 women in the United States who are diagnosed with ovarian cancer every year, onl

Updated on:June 04,2024 4

Researchers study the risk of false positives in colon cancer screening

by IDIBELL-Bellvitge Biomedical Research InstituteCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Colorectal cancer can develop for months without producing any s

Updated on: June 04,2024 8

Researchers study the risk of false positives in colon cancer screening

by IDIBELL-Bellvitge Biomedical Research InstituteCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Colorectal cancer can develop for months without producing any s

Updated on:June 04,2024 8

Simple test could lead to more personalized treatment of rare ovarian cancer

by University of New South WalesKaplan Meier curves of overall survival of ‘high’, ‘medium’ and ‘low’ tertiles of mRNA expression of THSB2 (left) and TAGLN (right) in MOC (n=185). Credit:Cl

Updated on: January 29,2024 20

Simple test could lead to more personalized treatment of rare ovarian cancer

by University of New South WalesKaplan Meier curves of overall survival of ‘high’, ‘medium’ and ‘low’ tertiles of mRNA expression of THSB2 (left) and TAGLN (right) in MOC (n=185). Credit:Cl

Updated on:January 29,2024 20

Researchers discover a common link among diverse cancer types

by Rockefeller UniversityCredit: CC0 Public DomainCancer, in all its forms, seems to always involve uncontrolled cell growth; but there are thousands of ways in which cells can lose control of th

Updated on: June 22,2024 3

Researchers discover a common link among diverse cancer types

by Rockefeller UniversityCredit: CC0 Public DomainCancer, in all its forms, seems to always involve uncontrolled cell growth; but there are thousands of ways in which cells can lose control of th

Updated on:June 22,2024 3

Researchers describe a mechanism inducing self-killing of cancer cells

by The Korea Advanced Institute of Science and Technology (KAIST)Professor Kim (left) and lead author Lee. Credit: The Korea Advanced Institute of Science and Technology (KAIST)Researchers have d

Updated on: June 08,2024 3

Researchers describe a mechanism inducing self-killing of cancer cells

by The Korea Advanced Institute of Science and Technology (KAIST)Professor Kim (left) and lead author Lee. Credit: The Korea Advanced Institute of Science and Technology (KAIST)Researchers have d

Updated on:June 08,2024 3

Sharp pain in your feet? Researchers test promising therapy for cancer patients' neuropathy

by Leslie Orr,University of Rochester Medical CenterCredit: Unsplash/CC0 Public DomainA wearable, app-controlled wireless device that stimulates nerves in the legs and feet may help individuals

Updated on: April 09,2024 0

Sharp pain in your feet? Researchers test promising therapy for cancer patients' neuropathy

by Leslie Orr,University of Rochester Medical CenterCredit: Unsplash/CC0 Public DomainA wearable, app-controlled wireless device that stimulates nerves in the legs and feet may help individuals

Updated on:April 09,2024 0

Testosterone therapy may protect against breast cancer in trans masculine individuals

by Jacqueline Mitchell,Beth Israel Deaconess Medical Centera) Lobular atrophy was assessed by the pathologists using four categories. b) The duration of testosterone therapy (TT) significantly c

Updated on: August 03,2024 0

Testosterone therapy may protect against breast cancer in trans masculine individuals

by Jacqueline Mitchell,Beth Israel Deaconess Medical Centera) Lobular atrophy was assessed by the pathologists using four categories. b) The duration of testosterone therapy (TT) significantly c

Updated on:August 03,2024 0

A new therapeutic target against the most common lung cancer

by University of BarcelonaFrom left to right: Marselina Arshakyan, Elba Marín (front), Paula Duch, Cristina Teixidó, Noemí Reguart, Rafael Ikemori, Jordi Alcaraz, Marta Gabasa and Natalia Díaz. C

Updated on: February 23,2024 12

A new therapeutic target against the most common lung cancer

by University of BarcelonaFrom left to right: Marselina Arshakyan, Elba Marín (front), Paula Duch, Cristina Teixidó, Noemí Reguart, Rafael Ikemori, Jordi Alcaraz, Marta Gabasa and Natalia Díaz. C

Updated on:February 23,2024 12

ASH: A+AVD beats ABVD for advanced Hodgkin's lymphoma

(HealthDay)—For patients with advanced-stage Hodgkin's lymphoma, brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A+AVD) have superior efficacy to doxorubicin, bleomycin, vinblastin

Updated on: March 30,2024 14

ASH: A+AVD beats ABVD for advanced Hodgkin's lymphoma

(HealthDay)—For patients with advanced-stage Hodgkin's lymphoma, brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A+AVD) have superior efficacy to doxorubicin, bleomycin, vinblastin

Updated on:March 30,2024 14

Drug combo heralds major shift in chronic lymphocytic leukemia treatment

by Stanford University Medical CenterCancer cells. Credit: Dr. Cecil Fox, National Cancer InstituteA combination of two drugs keeps patients with chronic lymphocytic leukemia disease-free and ali

Updated on: May 23,2024 4

Drug combo heralds major shift in chronic lymphocytic leukemia treatment

by Stanford University Medical CenterCancer cells. Credit: Dr. Cecil Fox, National Cancer InstituteA combination of two drugs keeps patients with chronic lymphocytic leukemia disease-free and ali

Updated on:May 23,2024 4

Treatment of advanced non-small cell lung cancer with driver mutations

by Higher Education PressGraphical abstract. Credit:Frontiers of Medicine(2023). DOI: 10.1007/s11684-022-0976-4Lung cancer is the leading cause of cancer-related death worldwide. Improved

Updated on: March 30,2024 0

Treatment of advanced non-small cell lung cancer with driver mutations

by Higher Education PressGraphical abstract. Credit:Frontiers of Medicine(2023). DOI: 10.1007/s11684-022-0976-4Lung cancer is the leading cause of cancer-related death worldwide. Improved

Updated on:March 30,2024 0